TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
JRS Pharma Oy
Closing information (x1000 NOK)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
99,113
|
108,485
|
100,872 |
Financial expenses |
18
|
19
|
27 |
Earnings before taxes |
20,053
|
20,198
|
15,826 |
Total assets |
60,097
|
55,891
|
63,022 |
Current assets |
27,877
|
20,552
|
29,643 |
Current liabilities |
13,293
|
14,902
|
13,247 |
Equity capital |
46,213
|
40,119
|
48,825 |
- share capital |
1,526
|
1,606
|
1,520 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
76.9%
|
71.8%
|
77.5% |
Turnover per employee | |||
Profit as a percentage of turnover |
20.2%
|
18.6%
|
15.7% |
Return on assets (ROA) |
33.4%
|
36.2%
|
25.2% |
Current ratio |
209.7%
|
137.9%
|
223.8% |
Return on equity (ROE) |
43.4%
|
50.3%
|
32.4% |
Change turnover |
-4,007
|
1,921
|
10,234 |
Change turnover % |
-4%
|
2%
|
11% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.